AbCellera Biologics Inc.
ABCL
$3.85
$0.071.85%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -47.15M | -28.61M | -30.53M | -40.11M | -29.89M |
| Total Depreciation and Amortization | 9.11M | 7.41M | 7.26M | 7.12M | 6.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.02M | 13.94M | 15.60M | 11.84M | 24.85M |
| Change in Net Operating Assets | 1.41M | 7.16M | 27.57M | -22.91M | 28.99M |
| Cash from Operations | -19.61M | -106.00K | 19.90M | -44.06M | 30.91M |
| Capital Expenditure | -14.43M | -20.33M | -27.20M | -14.98M | -12.33M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.89M | 7.55M | -7.19M | -134.63M | -4.73M |
| Cash from Investing | -24.32M | -12.79M | -34.39M | -149.61M | -17.06M |
| Total Debt Issued | 3.95M | 7.00M | 148.00K | 490.00K | 349.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -185.00K | -372.00K | 271.00K | -948.00K | 0.00 |
| Cash from Financing | 3.77M | 6.63M | 419.00K | -458.00K | 349.00K |
| Foreign Exchange rate Adjustments | 1.07M | -1.06M | 797.00K | -213.00K | 364.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.10M | -7.33M | -13.27M | -194.34M | 14.56M |
